Girard Partners’s Pfizer PFE Stock Holding History

Girard Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.41M	Buy	50,433 +2,561	+5%	+$70.5K	0.13%	117
2024 Q1	$1.33M	Sell	47,872 -4,345	-8%	-$121K	0.13%	128
2023 Q4	$1.5M	Sell	52,217 -7,688	-13%	-$232K	0.15%	120
2023 Q3	$1.99M	Sell	59,905 -132	-0.2%	-$4.67K	0.22%	94
2023 Q2	$2.2M	Buy	60,037 +697	+1%	+$27.1K	0.23%	88
2023 Q1	$2.42M	Sell	59,340 -166	-0.3%	-$7.17K	0.27%	80
2022 Q4	$3.05M	Buy	59,506 +8,116	+16%	+$389K	0.35%	75
2022 Q3	$2.25M	Sell	51,390 -1,431	-3%	-$69.5K	0.3%	81
2022 Q2	$2.77M	Buy	52,821 +908	+2%	+$46.3K	0.35%	77
2022 Q1	$2.69M	Buy	51,913 +323	+0.6%	+$16.8K	0.29%	87
2021 Q4	$3.05M	Sell	51,590 -686	-1%	-$34K	0.33%	86
2021 Q3	$2.25M	Sell	52,276 -1,886	-3%	-$83.6K	0.28%	88
2021 Q2	$2.12M	Sell	54,162 -5,360	-9%	-$208K	0.27%	89
2021 Q1	$2.16M	Sell	59,522 -1,684	-3%	-$59.8K	0.31%	85
2020 Q4	$2.25M	Sell	61,206 -9,645	-14%	-$354K	0.35%	80
2020 Q3	$2.47M	Sell	70,851 -3,354	-5%	-$118K	0.41%	70
2020 Q2	$2.3M	Sell	74,205 -6,639	-8%	-$226K	0.42%	68
2020 Q1	$2.5M	Buy	80,844 +4,818	+6%	+$164K	0.5%	57
2019 Q4	$2.83M	Buy	76,026 +1,010	+1%	+$36K	0.47%	64
2019 Q3	$2.56M	Sell	75,016 -20,964	-22%	-$762K	0.48%	67
2019 Q2	$3.94M	Buy	95,980 +1,655	+2%	+$65.7K	0.7%	47
2019 Q1	$3.8M	Buy	94,325 +1,418	+2%	+$56.8K	0.71%	44
2018 Q4	$3.85M	Sell	92,907 -3,793	-4%	-$157K	0.81%	39
2018 Q3	$4.04M	Sell	96,700 -14,635	-13%	-$563K	0.72%	38
2018 Q2	$3.83M	Buy	111,335 +1,591	+1%	+$54.4K	0.72%	43
2018 Q1	$3.69M	Buy	109,744 +1,091	+1%	+$37.5K	0.86%	35
2017 Q4	$3.73M	Sell	108,653 -2,571	-2%	-$87.7K	0.72%	46
2017 Q3	$3.77M	Buy	111,224 +11,409	+11%	+$367K	0.78%	41
2017 Q2	$3.18M	Buy	99,815 +21,872	+28%	+$690K	0.69%	49
2017 Q1	$2.53M	Buy	77,943 +24,354	+45%	+$768K	0.61%	54
2016 Q4	$1.65M	Buy	53,589 +5,303	+11%	+$162K	0.48%	69
2016 Q3	$1.55M	Buy	48,286 +994	+2%	+$33.2K	0.52%	65
2016 Q2	$1.58M	Buy	47,292 +1,061	+2%	+$33.9K	0.6%	56
2016 Q1	$1.3M	Buy	46,231 +2,586	+6%	+$73.9K	0.57%	57
2015 Q4	$1.34M	Buy	43,645 +2,609	+6%	+$82.1K	0.65%	53
2015 Q3	$1.22M	Buy	41,036 +3,260	+9%	+$105K	0.69%	50
2015 Q2	$1.2M	Buy	37,776 +2,025	+6%	+$66K	0.67%	50
2015 Q1	$1.18M	Sell	35,751 -3,089	-8%	-$98.2K	0.7%	52
2014 Q4	$1.15M	Sell	38,840 -6,150	-14%	-$176K	0.72%	47
2014 Q3	$1.26M	Sell	44,990 -3,745	-8%	-$105K	0.84%	43
2014 Q2	$1.37M	Sell	48,735 -1,473	-3%	-$42K	0.95%	41
2014 Q1	$1.53M	Buy	50,208 +5,556	+12%	+$166K	1.09%	33
2013 Q4	$1.3M	Buy	+44,652	New	+$1.3M	1.03%	35

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Girard Partners's PFE Position: Q2 2024 in Review

Girard Partners increased its Pfizer (PFE) stake by 5.3% in Q2 2024, buying an estimated $70.5K and bringing the position to 50,433 shares worth $1.41M. The position accounts for 0.13% of the portfolio, ranked #117.

Girard Partners first reported a position in PFE in Q4 2013 and has held it in 43 quarters since. The position peaked at $4.04M in Q3 2018. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Girard Partners held 50,433 shares of Pfizer worth $1.41M as of Q2 2024.
Girard Partners bought 2,561 Pfizer shares in Q2 2024, an estimated $70.5K.
Pfizer made up 0.13% of Girard Partners's portfolio in Q2 2024, its #117 holding.
Girard Partners first reported a position in Pfizer in Q4 2013 and has held it in 43 quarters since.
Girard Partners's Pfizer position peaked at $4.04M in Q3 2018.
2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.